Neonatal Economy: The Financialization of Human Fertility | Clinics, Private Equity, and the Multi-Billion Dollar Commercialization of Global Reproduction.DE. Este artículo no está disponible.
Idioma: inglés
Editorial: epubli, 2026
- Tapa blanda
- Nuevo

Librería: preigu, Osnabrück, Alemaniapreigu
Vendedor de 5 estrellas
Vendedor de IberLibro desde 5 de agosto de 2024
No disponible
Tapa blanda
Condición: Nuevo
EUR 32,99
Descripción del artículo del vendedor
Neonatal Economy: The Financialization of Human Fertility | Clinics, Private Equity, and the Multi-Billion Dollar Commercialization of Global [.] | Amber Torres | Taschenbuch | Englisch | epubli | EAN 9783565419395 | Verantwortliche Person für die EU: Neopubli GmbH (Imprint: epubli), Köpenicker Str. 154a, 10997 Berlin, produktsicherheit[at]epubli[dot]com | Anbieter: preigu.
N° de ref. del artículo 135180655
- Título
- Neonatal Economy: The Financialization of Human Fertility | Clinics, Private Equity, and the Multi-Billion Dollar Commercialization of Global Reproduction.DE
- Autor
- Amber Torres
- Editorial
- epubli
- Año de publicación
- 2026
- Estado
- Neu
- Encuadernación
- Taschenbuch
- Idioma
- inglés
- ISBN 10
- 3565419393
- ISBN 13
- 9783565419395
- Peso del artículo
- 459 gramos
- Dimensiones
- 10 x 210 x 297 mm
- Catálogos de vendedores
- Bücher
As global birth rates plummet and cultural shifts push family planning later into life, the demand for assisted reproductive technology has skyrocketed. What was once a deeply intimate, highly medicalized intervention has been aggressively transformed into one of the most lucrative and fiercely competitive sectors on Wall Street. Human fertility is no longer just a biological function; it is a premium financial asset class. This deep dive exposes the quiet, rapid takeover of independent fertility clinics by massive private equity firms. By consolidating IVF labs and standardizing deeply emotional medical procedures, these financial syndicates maximize profit margins at the absolute expense of patient care. You will navigate the opaque, hyper-inflated pricing structures of egg freezing, genetic screening, and surrogate matching, where desperate, vulnerable individuals are aggressively pressured into taking on crippling debt to finance the statistical gamble of reproduction. Deconstruct the ruthless, profit-driven architecture of the modern baby business. Understand the immense ethical conflicts of allowing corporate shareholders to dictate clinical reproductive protocols, and anticipate the societal consequences when the fundamental ability to start a family is entirely gated by extreme financial leverage.
“Sinopsis” puede pertenecer a otra edición de este título.